BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21791331)

  • 1. Comparison of one-year outcome of patients aged <75 years versus ≥75 years undergoing "rescue" percutaneous coronary intervention.
    De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Confessore P; Scappaticci M; Cifarelli A; Violini R
    Am J Cardiol; 2011 Oct; 108(8):1075-80. PubMed ID: 21791331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of one-year cardiac events with drug-eluting versus bare metal stent implantation in rescue coronary angioplasty.
    De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Stefanini GG; Caferri G; Violini R
    Am J Cardiol; 2011 Jan; 107(2):210-4. PubMed ID: 21129713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year clinical outcome of elderly patients undergoing angioplasty for ST-elevation myocardial infarction complicated by cardiogenic shock: the importance of 3-vessel disease and final TIMI-3 flow grade.
    De Felice F; Guerra E; Fiorilli R; Parma A; Musto C; Nazzaro MS; Violini R
    J Invasive Cardiol; 2014 Mar; 26(3):114-8. PubMed ID: 24610504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial.
    Carver A; Rafelt S; Gershlick AH; Fairbrother KL; Hughes S; Wilcox R;
    J Am Coll Cardiol; 2009 Jul; 54(2):118-26. PubMed ID: 19573727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.
    Gershlick AH; Stephens-Lloyd A; Hughes S; Abrams KR; Stevens SE; Uren NG; de Belder A; Davis J; Pitt M; Banning A; Baumbach A; Shiu MF; Schofield P; Dawkins KD; Henderson RA; Oldroyd KG; Wilcox R;
    N Engl J Med; 2005 Dec; 353(26):2758-68. PubMed ID: 16382062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary versus rescue percutaneous coronary intervention in patients with acute myocardial infarction.
    Gimelli G; Kalra A; Sabatine MS; Jang IK
    Acta Cardiol; 2000 Jun; 55(3):187-92. PubMed ID: 10902044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AngioJet Rheolytic thrombectomy during rescue PCI for failed thrombolysis: a single-center experience.
    Sherev DA; Shavelle DM; Abdelkarim M; Shook T; Mayeda GS; Burstein S; Matthews RV
    J Invasive Cardiol; 2006 Jul; 18 Suppl C():12C-16C. PubMed ID: 16883026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
    Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN
    J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
    Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
    Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
    D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
    Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year clinical outcome of patients treated with or without abciximab in rescue coronary angioplasty.
    De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Confessore P; Scappaticci M; Violini R
    Int J Cardiol; 2013 Mar; 163(3):294-298. PubMed ID: 21703701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following radial versus femoral artery access in primary or rescue percutaneous coronary intervention in Scotland: retrospective cohort study of 4534 patients.
    Johnman C; Pell JP; Mackay DF; Behan M; Slack R; Oldroyd KG; Berry C
    Heart; 2012 Apr; 98(7):552-7. PubMed ID: 22337951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
    Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.